PE20070344A1 - Regimenes para la administracion de las unidades de dosificacion de anticonceptivos monofasicos orales - Google Patents

Regimenes para la administracion de las unidades de dosificacion de anticonceptivos monofasicos orales

Info

Publication number
PE20070344A1
PE20070344A1 PE2006000686A PE2006000686A PE20070344A1 PE 20070344 A1 PE20070344 A1 PE 20070344A1 PE 2006000686 A PE2006000686 A PE 2006000686A PE 2006000686 A PE2006000686 A PE 2006000686A PE 20070344 A1 PE20070344 A1 PE 20070344A1
Authority
PE
Peru
Prior art keywords
administration
regimes
dosage units
date
oral contraceptives
Prior art date
Application number
PE2006000686A
Other languages
English (en)
Inventor
Victoria Jane Davis
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34940210&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20070344(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Organon Nv filed Critical Organon Nv
Publication of PE20070344A1 publication Critical patent/PE20070344A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fertilizers (AREA)

Abstract

SE REFIERE A UN METODO DE ANTICONCEPCION FEMENINA HUMANA EL CUAL COMPRENDE EL INICIO DE UNA FORMA DE DOSIFICACION EN LA FECHA NUMERICA "m + 4" DE UN MES HASTA LA FECHA NUMERICA "m" DEL MES SIGUIENTE, DONDE "m" ES UNA FECHA NUMERICA DESDE 1-24 Y EL METODO ES REPETIDAMENTE LLEVADO A CABO DURANTE AL MENOS DOS CICLOS. DICHA FORMA DE DOSIFICACION ES UNA UNIDAD ANTICONCEPTIVA ORAL MONOFASICA TAL COMO UNA PILDORA, QUE COMPRENDE A) UN ESTROGENO TAL COMO ESTRADIOL, ETINILO ESTRADIOL, ENTRE OTROS; Y B) UN PROGESTAGENO TAL COMO DESOGESTREL, NOMEGESTROL ACETATO, ENTRE OTROS. REFERIDA TAMBIEN A METODO DE ADMINISTRACION DE FECHAS NUMERICAS DE 1-23, 1-22 Y 1-21 DIAS
PE2006000686A 2005-06-21 2006-06-19 Regimenes para la administracion de las unidades de dosificacion de anticonceptivos monofasicos orales PE20070344A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05105484 2005-06-21

Publications (1)

Publication Number Publication Date
PE20070344A1 true PE20070344A1 (es) 2007-04-16

Family

ID=34940210

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2006000686A PE20070344A1 (es) 2005-06-21 2006-06-19 Regimenes para la administracion de las unidades de dosificacion de anticonceptivos monofasicos orales

Country Status (18)

Country Link
US (1) US20080206310A1 (es)
EP (2) EP1906968A4 (es)
JP (1) JP2008543935A (es)
KR (2) KR20080023747A (es)
CN (1) CN101511336A (es)
AR (1) AR054144A1 (es)
AU (2) AU2006259344A1 (es)
BR (2) BRPI0612519A2 (es)
CA (2) CA2611813C (es)
EC (2) ECSP088097A (es)
MX (1) MX2007016233A (es)
NO (1) NO20076347L (es)
PE (1) PE20070344A1 (es)
RU (1) RU2008102074A (es)
TW (1) TW200727920A (es)
UA (1) UA95447C2 (es)
WO (2) WO2007001888A2 (es)
ZA (2) ZA200710862B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
CN101500583B (zh) * 2006-07-12 2012-05-23 控制治疗（苏格兰）有限公司 含克林霉素盐酸盐的药物递送聚合物
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
TW200930343A (en) 2007-09-21 2009-07-16 Organon Nv Drug delivery system
CA2740004A1 (en) * 2008-10-08 2010-04-15 Agile Therapeutics, Inc. Transdermal delivery
US9198876B2 (en) 2008-10-08 2015-12-01 Agile Therapeutics, Inc. Contraceptive transdermal delivery of hormones
ES2795455T3 (es) 2008-10-08 2020-11-23 Agile Therapeutics Inc Suministro transdérmico
WO2010111488A1 (en) 2009-03-27 2010-09-30 Agile Therapeutics, Inc. Transdermal delivery
US10849857B2 (en) 2010-07-28 2020-12-01 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
AR081670A1 (es) 2010-06-29 2012-10-10 Leon Farma Sa Lab Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
US11351122B1 (en) 2010-07-28 2022-06-07 Laboratorios Leon Farma Sa Synthetic progestogens and pharmaceutical compositions comprising the same
US9603860B2 (en) 2010-07-28 2017-03-28 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
WO2015086489A1 (en) 2013-12-11 2015-06-18 Merck Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
EP3277241B1 (en) 2015-03-31 2023-12-20 Merck Sharp & Dohme B.V. Vaginal ring applicator
EP3893884A4 (en) * 2018-12-11 2022-09-14 Lupin Inc. EXTREMELY LOW COMBINATION OF ESTROGEN COMBINATIONS DRUG DELIVERY SYSTEM, AND METHODS AND USES THEREOF
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4292965A (en) * 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
US4736849A (en) * 1983-12-19 1988-04-12 Leonard Walter G Calendar-oriented pill dispenser
US4596576A (en) * 1984-10-12 1986-06-24 Akzo N.V. Release system for two or more active substances
US5010055A (en) * 1986-06-24 1991-04-23 The General Hospital Corporation Use of EGF to reverse the contraceptive activity of MIS
US5185374A (en) * 1988-05-11 1993-02-09 K.K. Ueno Seiyaku Oyo Kenkyujo Use of 15-ketoprostaglandin E or F compounds for uterine contraction
DE4202636A1 (de) * 1992-01-30 1993-08-05 Foldenauer Willi Vorrichtung und verfahren zur kennzeichnung von daten des inhalts einer verpackung
MX9301121A (es) * 1992-03-02 1993-09-01 Schering Ag Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina.
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
US6479475B1 (en) * 1996-07-26 2002-11-12 Wyeth Oral contraceptive
IL123813A0 (en) * 1997-04-11 1998-10-30 Akzo Nobel Nv Drug delivery system for two or more active substances
DE10045380A1 (de) * 2000-09-14 2002-04-04 Schering Ag Verfahren zur Kontrazeption und dessen Darreichungsform
US20020189141A1 (en) * 2001-06-14 2002-12-19 Kabushiki-Kaisha Musshu Calendar for administrating medicine as prescribed
US7017513B2 (en) * 2001-08-08 2006-03-28 Harry Giewercer Dosage reminder device and medication carton
WO2003082336A1 (en) * 2002-04-03 2003-10-09 Jencap Research Ltd. Female birth control method
TW200404552A (en) * 2002-05-30 2004-04-01 Akzo Nobel Nv Self administered contraception
PT1462107E (pt) * 2003-03-28 2009-01-02 Pantarhei Bioscience Bv Método contraceptivo feminino e kit para ser usado neste método
US20040222123A1 (en) * 2003-05-06 2004-11-11 Barr Laboratories, Inc. Kit for pharmaceuticals
US20050113350A1 (en) * 2003-11-26 2005-05-26 Bernd Duesterberg Extended use combination comprising estrogens and progestins
US20050149362A1 (en) * 2003-12-30 2005-07-07 Peterson Per A. System and method for visually presenting digital patient information for future drug use resulting from dosage alteration
US7381393B2 (en) * 2004-10-07 2008-06-03 The Regents Of The University Of California Process for sulfur removal suitable for treating high-pressure gas streams
US20060079491A1 (en) * 2004-10-08 2006-04-13 Andreas Sachse Method of female hormonal contraception using a fixed extended cycle hormonal preparation containing dienogest and ethinyl estradiol

Also Published As

Publication number Publication date
CA2611813C (en) 2013-10-15
CN101511336A (zh) 2009-08-19
MX2007016233A (es) 2008-03-10
KR20080023747A (ko) 2008-03-14
NO20076347L (no) 2008-03-17
CA2611779A1 (en) 2007-01-04
JP2008543935A (ja) 2008-12-04
ECSP088097A (es) 2008-02-20
BRPI0612519A2 (pt) 2016-09-13
ZA200710865B (en) 2008-10-29
UA95447C2 (ru) 2011-08-10
AU2006262546A1 (en) 2007-01-04
EP1898849A2 (en) 2008-03-19
WO2006138503A3 (en) 2009-05-14
AR054144A1 (es) 2007-06-06
BRPI0612263A2 (pt) 2012-04-24
AU2006262546B2 (en) 2013-09-05
ZA200710862B (en) 2009-05-27
WO2007001888A2 (en) 2007-01-04
CA2611813A1 (en) 2006-12-28
KR20080025168A (ko) 2008-03-19
RU2008102074A (ru) 2009-07-27
TW200727920A (en) 2007-08-01
WO2006138503A2 (en) 2006-12-28
WO2006138503A8 (en) 2007-07-05
WO2007001888A3 (en) 2007-05-10
US20080206310A1 (en) 2008-08-28
EP1898849A4 (en) 2013-01-23
EP1906968A2 (en) 2008-04-09
AU2006259344A1 (en) 2006-12-28
EP1906968A4 (en) 2013-04-10
ECSP088098A (es) 2008-02-20

Similar Documents

Publication Publication Date Title
PE20070344A1 (es) Regimenes para la administracion de las unidades de dosificacion de anticonceptivos monofasicos orales
PE20051038A1 (es) Uso extendido de combinacion que comprende estrogenos y progestinas
ES2558030T3 (es) Método anticonceptivo oral multifásico de ciclo prolongado
AR049112A1 (es) Composiciones, metodos y kit, para el tratamiento de trastorno disforico premenstrual
CR7420A (es) Composiciones farmaceuticas que comprenden uno o varios esteroides, uno o varios componentes de tetrahiidrofolatos y vitamina b12
HRP20070188B1 (hr) Farmaceutska kombinacija etinilestradiola i drospirenona za upotrebu kao kontracepcijskog sredstva
RU2007148080A (ru) Составы и способы для лечения симптомов, связанных с циклом
AR057060A1 (es) Composiciones de tanaproget que contienen etinil estradiol
ES2693085T1 (es) Uso de estriol en bajas dosis
PE20020425A1 (es) Metodo de anticoncepcion y forma de administracion del mismo
KR960706344A (ko) 호르몬 피임 및/또는 여드름 치료 수단 및 방법(means and method for hormonal contraception and/or the treatment of acne)
PE20070208A1 (es) Anticoncepcion oral con trimegestona
ATE493132T1 (de) Arzneimittel umfassend wenigstens ein gestagen
PE20040068A1 (es) Decanoato, undecanoato y dodecanoato de etonogestrel
PE20070119A1 (es) Nuevos regimenes para dispositivos de suministro controlado de farmacos para la anticoncepcion
AR065816A1 (es) Regimen anticonceptivo oral
PE20060368A1 (es) Anticonceptivo hormonal conteniendo una combinacion de etinilestradiol y acetato de clormadinona
AR049195A1 (es) Uso de una combinacion de etinilestradiol y acetato de clormadinona para la preparacion de un medicamento
CA2410993A1 (en) Starter kit for low dose oral contraceptives
Roehr Microbicide offers no protection against HIV infection
DK1937274T3 (da) Anvendelse af estradiolvalerat i kombination med dienogest til oral behandling af dysfunktionel uterin blødning i enhed med en oral kontraception
UA131972U (uk) Спосіб лікування захворювань пародонта у жінок, які приймають оральні гормональні контрацептиви
Sakamoto et al. Effect of intrauterine levonorgestrel system in women with abnormal menstrual bleeding
TH98166B (th) การจัดการการเกิดการตกเลือดอย่างมากในการจัดควบคุมยาคุมกำเนิดชนิดฮอร์โมนแบบมีการขยายเวลา
Gruber et al. Satisfaction and compliance of 1333 users of transdermal contraception in private gynaecological practice in Austria

Legal Events

Date Code Title Description
FC Refusal